Abstract:Background: Glioma is a common primary central nervous system tumor, and there is still a lack of effective therapeutic drugs that can effectively improve the survival rate of patients in clinical. Bufalin has a good effect in the treatment of various tumors, but the mechanism of how it promotes the apoptosis of glioma cells is still unclear. The aim of this study was to investigate the drug target of bufalin acting on glioma cells, and to clarify the mechanism of apoptosis. Methods: Cell viability and proliferation were evaluated by cck-8 and colony formation assay. Then, the cell cycle and apoptosis, intracellular ion homeostasis, oxidative stress levels and mitochondrial damage were detected after bufalin treatment. DARTS-PAGE technology combined with LC-MS/MS were employed to explore the drug targets of bufalin on U251 cells. Molecular docking and western blot were used to further identify the potential targets. siRNA of Annexin A2 and a DRP1 protein inhibitor Mdivi-1 were also used to verify the target of bufalin.Results: Bufalin upregulated the expression of cytochrome C, cleaved caspase 3, p-Chk1 and p-p53 proteins to cause U251 cell apoptosis and cycle arrest in S phase. Bufalin can also induce oxidative stress in U251 cells, destroy intracellular ion homeostasis, and cause mitochondrial damage. The expression of mitochondrial separation/fusion-related proteins in U251 cells was abnormal, Annexin A2 and DRP1 protein were translocated from cytoplasm to mitochondria, and MFN2 protein was released from mitochondria into cytoplasm after bufalin treatment, which disrupted the mitochondrial division/fusion balance of U251 cells. Conclusions: Our research indicated that bufalin can cause Annexin A2 and DRP1 oligomerization to be located on the surface of mitochondria, and disrupt the mitochondrial division/fusion balance to induce U251 cell apoptosis.

Tubeimoside-1 induces apoptosis in human glioma U251 cell line by up-regulating FADD/caspase-8/caspase-3 pathway

Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway.

[Effect of nano-liposome sustained elemene in inducing cell apoptosis of C6 glioma].

Triptolide Induces Apoptosis in Myelodysplastic Syndromes MUTZ-1 Cells Through Activation of Caspases and Down-Regulation of IAPs

[Study of Triptolide-Induced Apoptosis in MUTZ-1 Cells and Its Allied Mechanism].

Effect of Survivin Targeting on Cell Proliferation and Apoptosis in Glioma Cell Line

Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment

Pyrrolidine Dithiocarbamate Sensitizes U251 Brain Glioma Cells to Temozolomide Via Downregulation of MGMT and BCL-XL

Bufalin Induced Mitochondrial Dysfunction Promotes Apoptosis of Glioma Cells by Regulating Annexin A2 and DRP1 Proteins

[Action of Apoptosis-Induced Ligand Gene in Relation to Tumor Necrosis Factor on Human Colon Cancer Cell Line HT29].

Effects of Wogonin on the Apoptosis of Human Glioma Cell Line U251

MAP30 Promotes Apoptosis of U251 and U87 Cells by Suppressing the LGR5 and Wnt/β-catenin Signaling Pathway, and Enhancing Smac Expression.

Mechanism of temozolomide-induced antitumour effects on glioma cells

Sensitization Of Glioma Cells To Tamoxifen-Induced Apoptosis By Pl3-Kinase Inhibitor Through The Gsk-3 Beta/Beta-Catenin Signaling Pathway

Gambogenic acid-induced time- and dose-dependent growth inhibition and apoptosis involving Akt pathway inactivation in U251 glioblastoma cells

Tubeimoside I induces accumulation of impaired autophagolysosome against cervical cancer cells by both initiating autophagy and inhibiting lysosomal function

Baohuoside I via mTOR Apoptotic Signaling to Inhibit Glioma Cell Growth

The Role of Cell Apoptosis in Glioma Chemotherapy Evaluation

Ursolic acid inhibits proliferation and induces apoptosis in human glioblastoma cell lines U251 by suppressing TGF-β1/miR-21/PDCD4 pathway.

Tubeimoside I-induced lung cancer cell death and the underlying crosstalk between lysosomes and mitochondria

Triptolide induces apoptosis of glioma cells by inhibiting NF-κB activation during oxidative stress